organs, the women were left with those deemed less important, which happened to include the brain and nervous system [1] [2] [3] [4] .
In the 1950's the pathogenesis, lesions, and clinical signs of kuru were noted to shared numerous similarities to an affliction of sheep, commonly known as scrapie. Most notably in its comparison to kuru, scrapie (so called due to the nature of affected animals to waste away, and "scrape" away their own wool) produced similar spongiform lesions in brain tissues [1] [2] [3] [4] . Ovine genetic predispositions to scrapie infection have been linked to certain polymorphisms in the prion protein at codons 136, 154, and 171 [5, 6] . Infected sheep display neurodegenerative symptoms including but not limited to: self-isolation, circling, anorexia/weight loss, and an unkempt hair coat [5] . They also demonstrate self-mutilating behavior by rubbing against objects and breaking off clumps of wool, effectively scraping off their own hair coat-lending the disease its name. As was seen with kuru, once individuals begin to show symptoms of scrapie, they continue to steadily and irreversibly decline.
Spongiform lesions in the brain had also been described in another human disorder, Creutzfeldt-Jakob disease (CJD), along with other rare neurodegenerative diseases such as Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia [7] . Like scrapie and kuru, these diseases were invariably progressive and ultimately fatal yet the root cause was long unknown [7] . However, it became apparent that the etiologic agent was unlike any pathogen that had been documented previously.
Stanley Prusiner, documented a number of distinctions through his work with scrapie. In 1982 he asserted the infectious particles were proteinaceous in nature, rather than viral or bacterial [8] . This was evidenced by failure to deactivate the infectious agent through use of methods specific for destroying nucleic acids, decreased infectivity following exposure to proteases, a heterogeneous nature, and small size of the infectious particles [8] . This new class of pathogen, unique in its ability to replicate without nucleic acids, was deemed a "prion"
(derived from "infectious protein").
With the emergence of a new spongiform encephalopathy, variant Creutzfeldt-Jakob disease (vCJD), in the 1980's identification and further study of the causative agent became imperative. vCJD produced similar lesions to sporadic CJD, however CJD was considered a slowly progressing neurodegenerative disease that developed later in life. In contrast, vCJD instead affected healthy young adults and progressed much more rapidly (2 years or less) [9, 10] . Eventually, the origin of vCJD was traced to yet another neurodegenerative disorder:
bovine spongiform encephalopathy (BSE) that was seen in cattle fed post-rendering scrap material, i.e. the meat and bone meal of other cattle [11] . The transmissibility of BSE to primates was confirmed in studies using lemurs and macaques inoculated with infectious brain homogenate [12] [13] [14] . This was done in part by passage of BSE through mice and then inoculating non-human primates. The resulting strain of BSE was then found to quickly adapt to primates and exhibited very similar lesions and pathology to those seen in patients with vCJD [14] .
As time went on, the similarities between scrapie, BSE, vCJD, CJD, and other spongiform encephalopathies could not be ignored, and so these diseases were grouped together and classified as transmissible spongiform encephalopathies (TSEs). Additionally, prions became more and more widely accepted as the root cause of TSEs.
This prion has been shown to be a misfolded isoform of a protein found in normal neurons (and other cells). The exact function of the cellular isoform remains unknown, however it has been linked to roles in reduction of oxidative stress, potentiating long-term memories, and cell adhesion/signaling [15] . While the abnormal prion protein, (PrP Sc ) and its normal cellular isoform (PrP C ) share identical amino acid sequences, their folded configurations differ in shape [16] . This difference in shape is also associated with different biophysical and chemical properties. PrP Sc is more resistant to denaturation by heat, acid, and proteases than its cellular counterpart (PrP C ) [17] . The lower energy form is that of the infectious prion, PrP Sc and as such PrP C is induced to rearrange and refold itself into the infectious prion form when the two come into contact 69 . This results in a chain reaction as more and more altered prion proteins exist and come into contact with more and more of their normal cellular counterparts. Infectious prions then accumulate intracellularly within the Golgi apparatus before extending into extracellular space as fibrils 11 . Over time, this results in vacuolar neuronal degeneration and neuronal 4 apoptosis. This the family of disease caused by aberrant prion protein replication has come to be known as transmissible spongiform encephalopathies (TSEs) [2] [3] [9] [10] 8] .
Prion pathogenicity has be further confirmed after isolation from infected animals. For example, homogenate from animals infected with scrapie inoculated into naïve animals has been shown to produce disease [8] . Furthermore, knockout animals that do not express cellular prion proteins have proven unsusceptible to TSE infection [8] .
Thesis organization
This thesis provides an introduction to diseases caused by prions, and the characteristic properties of both the infectious prion protein and its normal cellular isoform. The following chapter provides a review of the existing literature on various inoculation routes used for experimentally generating TSE pathology, prion-associated retinal pathology, and TSE pathology studies using a time-course study design. Chapter 3 provides a manuscript describing a study of scrapie associated retinal pathology; materials and methodology are described, along with results and discussion sections, with figures following at the end. Chapter 4 gives a summary of findings, recommendations for future research, and concluding remarks.
CHAPTER 2: LITERATURE REVIEW TSE research
As research into the nature of diseases caused by prions progressed, both time and cost constraints necessitated development of an appropriate model species for study. Selection of an appropriate model was complicated by both the long incubation periods seen with most TSEs, and a relative host specificity. In natural hosts, prion diseases develop gradually over the course of months to years. Scrapie most often occurs in 1-5 year old sheep, and BSE most often manifests in 4-6 year old cattle though the incubation period can range from 2-18 years [5] .
Additionally, with the exception of BSE and vCJD, there are few cases in which a prion protein found in one species has been shown to be naturally infectious in another species.
These barriers were overcome through development of reliable methods of passing scrapie through rodents. The significantly shorter lifespan of hamsters (and later mice) proved immensely beneficial to studies of prion-related pathology over time. In contrast to larger animals with incubation periods of months to years, mice incubation periods tend to last 200-300 days or less [18] . Studies in mice also confer an economical benefit, especially when compared to research performed with primates, as was done in studies to support the infectivity of spongiform encephalopathies to humans [12] [13] [14] .
Moira Bruce and her colleagues furthered research in using mouse models for passage of TSEs by devising a scoring system, to assist with identifying strains of prion diseases. This scoring system grades vacuolar degeneration (on a scale from 1-5) in 9 different gray matter sections: the dorsal medulla, cerebellar cortex, superior colliculus, hypothalamus, medial thalamus, hippocampus, septum, medial cerebral cortex at the level of the thalamus, and the medial cerebral cortex at the level of the septum. Additionally, 3 white matter sections within the cerebellum, mesencephalic tegmentum, and pyramidal tract are also observed. These scores have been used to create a characteristic lesion profile for many different "strains" of prion disease, which exhibit different patterns of cerebral and cerebellar vacuolation [19] [20] [21] [22] .
These lesion profiles have also been shown to differ between routes of infection [23] .
Different routes of inoculation
A wide variety of inoculation routes have been used in studying TSEs. These include intracerebral (IC), intraperitoneal (IP), and intraocular (IO), among others. While intracerebral inoculations generally produce disease more rapidly, they do not necessarily mimic the disease course as it occurs naturally. Naturally, infectious prion diseases are thought to be commonly acquired by ingestion, rather than direct inoculation into the CNS. A discussion of the differences seen with routes of inoculation follows, arranged from most to least effective at producing disease.
Intracerebral (IC) inoculations
Intracerebral inoculations have largely been associated with the most significant pathology [18, 24] . In time-course studies, mice inoculated with mouse-adapted scrapie have reliably produced lesions more quickly than those seen with more peripheral routes (e.g. IP) [18, 25] . In scrapie-infected mice, IC inoculations have produced lesions 110 days sooner than IP inoculations, and show a much shorter overall disease course (with death occurring around 170 days post inoculation for the IC route and at approximately 280 days post inoculation for the IP route) [18] . Similar results were seen in BSE infected mice [18] . Lesions in IC-inoculated mice were also found to be more severe, though they often followed similar distributions to those seen with the more peripheral routes [18] . Similarly, hamsters inoculated intracerebrally with 263K scrapie developed disease significantly more rapidly than their counterparts that were inoculated via other routes (e.g. IC, IP, IO, as well as intracardiac and intramuscular inoculations) [24] .
Intralingual inoculations
An intralingual route of inoculation has also been used in comparison to IC using scrapie in its natural ovine host. The pathology and progression of disease seen with the two routes were very similar, which may be in part attributed to the heavy innervation of the tongue by cranial nerves 9 and 12, which provide direct access to the brainstem and CNS [26] .
Intraperitoneal inoculations
This route of infectious prion injection is moderately effective at producing disease.
However as mentioned above, though it can show a similar distribution to the intracerebral route, it is often less pronounced and development of significant lesions is delayed [18, 24, 27] .
Furthermore, prion accumulation was somewhat decreased for mice inoculated with scrapie and BSE when brains from IP inoculated animals were compared to IC inoculated animals [18] .
This delay of prion accumulation and decreased overall accumulation in IP inoculated animals (when compared to IC inoculated animals) is not limited to the CNS, and has also been noted in lymphatic tissue [25] .
Intraocular inoculations
Many studies that have used intraocular (IO) inoculations did not compare directly with other routes. However, to summarize, these studies did produce significant disease in the retina [28, [29] [30] . IO inoculation has also been shown to produce more disease in the inner retinal layers than extraocular inoculations [31] . This route has also been shown to produce CNS disease by anterograde transport via the optic nerve [32] . Though when CNS disease is produced it is not as severe as that seen with direct IC inoculation [24] .
Oral and intragastric routes
Interestingly, the oral and intragastric routes would be most synonymous with what is thought to be the natural route of infection: ingestion. However, intragastric inoculation of scrapie into hamsters was not proven effective experimentally in causing disease [24] . Oral inoculation of CWD into cervids also has been shown to be ineffective in reliably producing disease except at high doses [33-34].
However, while a variety of inoculation routes have used experimentally, there is little to no literature comparing the pathological and immunohistochemical differences seen in the retinas using different inoculation protocols. 
Scrapie in sheep (and goat) retinas
As mentioned previously, scrapie naturally infects sheep (and more rarely goats); the disease most often occurs in sheep aged 1-5 years [5] . While scrapie is not seen commonly in goats they are known to be susceptible.
However, because it is not often seen, literature discussing scrapie in goats is limited, and discussion of associated retinal pathology is sparse. IHC showing PrP Sc accumulation in the absence of other retinal pathology has been reported in goats infected with scrapie, though this was thought to be preceding retinal degeneration [47] .
Scrapie in rodents
As previously discussed, prion diseases do not often cross species barriers, and so the development of strains of scrapie that were infectious to rodents has proven invaluable in TSE research. Mouse-adapted scrapie strains in have allowed mapping the disease process in cephalic tissues [19] [20] [21] , and similarly many studies have shown changes in the retina that have been attributed to PrP Sc protein accumulation.
Early studies of scrapie in rodents often involved hamsters, using a strain of scrapie called 263K. Histopathologic results showed similar findings to those seen in sheep as retinal degeneration was notable, progressive, and most severe in outer retinal layers [37-38,48-51].
Electron microscopy also has been used to evaluate hamster retinal tissues following infection with scrapie. This again showed that progressive retinal degeneration occurred, was most severe in outer retinal layers, but occurred after prion protein accumulation [50] . This supported suspicions (though did not necessarily prove) that prions could be directly retinotoxic, and that retinal degeneration was not necessarily subsequent to generalized neurodegeneration.
Subsequent studies explored the retinal pathology in both hamster and mouse eyes inoculated with 263K scrapie. Interestingly, hamster eyes were noted to accumulate significantly more prion protein than was observed in mouse eye tissue [28, 50] .
However, one method to circumvent these differential findings was to use transgenic mice expressing hamster PrP. In studies which used this method, tissues were analyzed after terminal stages were reached for each of the following groups: one expressing hamster prion proteins, one expressing hamster GFAP, and one expressing hamster neuron-specific enolase (NSE) [29] [30] . After intra-ocular inoculation with a hamster-adapted 263K scrapie the only group to develop retinal pathology was that which expressed hamster prion protein, further supporting the theory that retinal degeneration in TSEs was directly related to PrP Sc replication and accumulation within the eye. In subsequent work the activation of astroglial cells in scrapie-inoculated retinas was also noted [29] .
Mouse-adapted forms of scrapie were eventually developed and histopathologic lesions were observed to follow a similar pattern to results previously reported. A study using 79A Other studies have focused on documenting pathology and/or PrP Sc in infected tissues.
In sequential-kill studies using 2-month collection intervals, PrP Sc immunoreactivity has been documented in the brainstem prior to development of spongiform lesions at the obex in BSE infected cattle (though only after a dormant period lasting >1 year) [65] . Other work involving the entire cerebrum, cerebellum, and brainstem has shown little to no change in PrP Sc accumulation and GFAP immunoreactivity in early time points, but drastic increases in mid-late stages of disease in murine models of scrapie and BSE [18] .
Still other studies have noted disease progression over time in nervous, lymphatic, and other tissues in lesser-known TSEs, including TME [66].
However, almost no evidence exists in the literature for studies that have evaluated changes in the retina over time, especially with documentation of prion accumulation in conjunction with retinal pathology.
Conclusions
Prions are novel pathogens that are unique in their ability to replicate without use of nucleic acids. The diseases they cause are invariably fatal, and some forms of TSEs are transmissible to humans, making research into effective antemortem diagnostics critical.
Retinal pathology has been documented in almost all TSEs, and may provide a means for antemortem diagnostics and/or animal screening tests at a herd level to guard against potential zoonotic transmission. Though prion diseases have been extensively researched, there is a lack of documentation of the course of disease as it occurs in the retina from the time of inoculation to terminal stages. Furthermore, it will also be useful to establish if and how pathology in the retinas varies with a direct inoculation into the CNS (intracerebral) versus a more peripheral route (e.g. intraperitoneal), as multiple inoculation routes have been used extensively studied in TSE studies.
14. Lasmézas, C. I., Deslys, J. P., Demaimay, R., Adjou, K. [2, 3] . This replication is unique among pathogens in that it requires no nucleic acid, and can take years to progress to manifestation of clinical signs. Prion diseases have been described in a number of species, including humans. Scrapie, the oldest known TSE, affects sheep and goats; others include chronic wasting disease (CWD) of cervids, Creutzfeldt-Jakob disease in humans, transmissible mink encephalopathy (TME), and bovine spongiform encephalopathy (BSE) [4, 5, 6] .
TSEs have much in common with other protein-accumulating neuropathies, e.g.
Parkinson's disease, Alzheimer's disease, and Huntington's disease [7] . However TSEs are distinct in having infectious forms, which allow for direct inoculation from infected individuals to naïve animals. This distinction among prion diseases can be exploited for research purposes and enables study of the common underlying pathogenic mechanisms from the earliest stages of disease. In particular, scrapie incubation time and pathologic profiles are well-defined in mouse models [8, 9] .
The purpose of this study was to compare retinal pathology associated with two experimental routes of scrapie inoculation: intracerebral inoculation (IC) to intraperitoneal (IP), and for these purposes we used the RML scrapie agent injected into C57Bl/6 mice. Retinal degeneration and/or accumulation of misfolded PrP Sc has been documented in a number of TSEs including: scrapie in sheep [10] [11] [12] [13] [14] , chronic wasting disease in elk [15] , transmissible mink encephalopathy [16] , feline spongiform encephalopathy in cats [17] , in addition to BSE in cattle [18] and variant Creutzfeldt-Jakob's disease in humans [19] . Due to this commonality of prionassociated retinal pathology, coupled with the fact that it is possible to monitor eye function in live animals using modalities such as optical coherence tomography [20, 21] , the hope is that this study will allow for development of retinal scans as a non-invasive, diagnostic tool for TSEs.
Here we have shown retinal PrP Sc accumulation, stress, and degeneration are detectable after approximately 80% of the incubation period in mice, for all detection methods and inoculation routes. However, disease severity was slightly lessened and progression was prolonged for intraperitoneally-inoculated animals.
Materials and methods:
Ethics Upon collection globes were collected into Bouin's fixative. Tissues were then embedded in paraffin for processing, sectioned at 4 microns, and affixed to slides for H&E staining and IHC.
Single label immunohistochemistry was performed using two primary antibodies: GFAP (Dako) and 6C2 (Central Veterinary Institute-WUR), which are described in further detail in the following paragraphs. Both primary antibodies were diluted in blocking solution consisting of 0.1% bovine serum albumin and 1.5% normal goat serum dissolved in 1X tris-buffered saline+ 0.05% polysorbate 20. To determine ideal antibody concentration for immunoreactivity and visibility of labeling, dilution curves were performed for optimization. Primary antibody detection was performed with Dako's HRP polymer (goat anti-mouse/rabbit utilizing horseradish peroxidase). The chromagen 3,3'-diaminobenzidine (DAB) was used for viewing, and hematoxylin was used as a counterstain. 1X tris-buffered saline solutions with 0.05% polysorbate 20 were also used for intermediate washes.
Retinal degeneration was measured by counts of cell bodies spanning the outer nuclear layer (ONL) of the retinas, made visible by hematoxylin stain. For each cross section, three counts were made in the central retina and averaged for a single value for each animal To assess the retinal response to stress, a polyclonal rabbit anti-glial fibrillary acidic protein (GFAP) was used at a 1:100 dilution in the retina. GFAP is a cytoskeletal protein upregulated by retinal Müller glia under stressed conditions [22] . Endogenous peroxidase in tissues was blocked by holding slides in a 3% hydrogen peroxide solution with a tris-buffered saline diluent for 20 minutes. Primary incubation time was one hour, secondary incubation for primary detection was 20 minutes, and DAB was left on for 5 minutes.
To Results were analyzed for significance using one-way ANOVA (analysis of variance) (p<0.05, confidence interval of 95%).
Results:
Retinal degeneration
Thinning of the outer nuclear later was noted in mice euthanized after showing neurologic disease. To quantify this retinal degeneration over the time-course of the study, 
PrP Sc accumulation in the retina
To investigate the time-course of PrP Sc accumulation in the retina, immunohistochemistry was used to label misfolded prion protein in fixed tissues. PrP Sc immunoreactivity was minimal for both inoculation routes until at or near clinical stages of disease, at which time retinal tissues were often diffusely labeled. Punctate labeling was occasionally visible as early as 90 days post inoculation in intracerebrally inoculated mice in the photoreceptor layer and outer nuclear layer ( Figure 3 ). However this was not a consistent finding and was seen even more rarely in intraperitoneally inoculated mice at >120 dpi.
PrP
Sc immunoreactivity was quantified using a subjective scoring system from -1 to 3.
Zero was the score of the tissues with maximum non-specific background staining. Three was the maximum specific PrP Previous research using scrapie passed through mice has shown intraperitoneally inoculated mice develop retinal lesions at later time points than intracerebrally inoculated mice [23] . Intracerebral inoculations in fact have consistently produced more severe disease and shown a higher degree of prion accumulation in the retina and other tissues, when compared to other routes in TSE studies done with various species [24, 25] .
The accumulation of PrP Sc in the retina was only somewhat consistent with previous results. In prior studies of scrapie-associated retinal pathology, PrP Sc labelling was first detected in the inner and outer plexiform layers and then extended into the outer nuclear layer, inner nuclear layer, photoreceptor layer, and ganglion cell layer with the highest accumulation seen in the ganglion cell layer [26, 27] . Our work showed very little accumulation in tissues prior to diffuse labeling, but when present punctate PrP Sc labelling first appeared in the PRL or ONL, and the most intense labeling occurred in the ONL.
However, retinal response to stress, as measured by GFAP expression by astrocytes and This time-course study work has documented how pathology develops in the retina over time, using a mouse model. While most changes were not significant until approaching the end of the incubation period, this narrows the window for future studies of retinal effects in more detail. We have also demonstrated differences in intraperitoneally inoculated mice and intracerebrally inoculated mice and how the two routes compare at different time points. In conclusion this work may provide groundwork for later studies in natural hosts. As has been alluded to in previous sections, little information exists as to when exactly pathology becomes detectable in the retina. Our study aimed to investigate this in further detail.
Our results showed retinal pathology did not occur until 80% of the incubation period had passed, and also that disease progressed more slowly in intraperitoneally (IP) inoculated mice as compared to those receiving intracerebral (IC) inoculations. The levels of accumulation of PrP Sc in IP mice occurring at clinical stages did still approach levels seen in IC mice, indicating that progression of disease was initially slow and more rapid at the later stages, regardless of inoculation route. This is consistent with prior research comparing IC inoculation to other routes.
Unfortunately, 30 day time periods were not adequate to determine the exact spread of prion accumulation in the retinas of scrapie-affected mice. Though some pinpoint lesions appeared in the photoreceptor layer and outer nuclear layer, it was difficult to say with certainty which areas the prions localized to first. Still, in later stages the most intense PrP Sc immunoreactivity often occurred at the edge of the outer nuclear layer and/or within the photoreceptor layer, which differed somewhat from previous studies of PrP Sc In any case, prion research remains relevant today, even though BSE and vCJD cases have drastically declined. Information obtained from TSE studies could also prove valuable to study of other, non-infectious protein misfolding neuropathies. Though not infectious, this list also includes a number of progressive, neurodegenerative diseases for which there is no cure, and diagnosis can often times be inexact. These include Alzheimer's disease, Parkinson's disease, dementia, and others which affect millions of people worldwide.
Concluding remarks
We have described PrP Sc accumulation and associated retinal degeneration in a murine TSE, providing a model in which to study the relationship between PrP Sc accumulation and neuronal cell death in more detail. This allows us to move forward with similar investigations in other species to improve knowledge of TSE pathology and improve diagnostics for this class of diseases, and other protein-misfolding diseases.
